EDGAR Filing Documents for 0001171843-17-003575

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001171843-17-003575

Filing Date

2017-06-09

Accepted

2017-06-09 16:34:33

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-3	fs3_060917.htm	S-3	494303
2	EXHIBIT 5.1	exh_51.htm	EX-5.1	6458
3	EXHIBIT 23.1	exh_231.htm	EX-23.1	2782
4	EXHIBIT 23.2	exh_232.htm	EX-23.2	1843
5	GRAPHIC	logo.jpg	GRAPHIC	47124
6	GRAPHIC	cooley.jpg	GRAPHIC	32744
	Complete submission text file	0001171843-17-003575.txt		616212

Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850

Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400

Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-218639 | Film No.: 17903374
SIC: 2834 Pharmaceutical Preparations